Exploiting differences in sialoside expression for selective targeting of MRI contrast reagents

Journal of the American Chemical Society

Volumn 121, Issue 17, 1999, Pages 4278-4279

  Lemieux, George A ^a   Yarema, Kevin J ^a   Jacobs, Christina L ^a   Bertozzi, Carolyn R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SIALIC ACID;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL SURFACE; CHEMICAL STRUCTURE; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG TARGETING; ELECTRON SPIN RESONANCE; NONHUMAN; REACTION ANALYSIS; STRUCTURE ANALYSIS;

EID: 0033526368     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja984228m     Document Type: Article

References (29)

1. Gupta, H.; Weissleder, R. MRI Clin. N. Am. 1996, 4, 171.
2. (a) Lauffer, R. B. Chem. Rev. 1987, 87, 901.
3. (b) Lanthanide Probes in Life, Chemical and Earch Sciences: Theory and Practice; Bunzil, J.-C. G., Choppin, G. R., Eds.; Elsevier: New York, 1989.
4. Sipkins, D. A.; Cheresh, D. A.; Kazemi, M. R.; Nevin, L. M.; Bednarski, M. D.; Li, K. C. P. Nat. Med. 1998, 4, 623.
5. (a) Fukuda, M. Cancer Res. 1996, 56, 2237.
6. (b) Jørgensen, T.; Berner, A.; Kaalhus, O.; Tveter, K. J.; Danielsen, H. E.; Bryne, M. Cancer Res. 1995, 55, 1817.
7. (c) Yang, J.-M.; Byrd, J. C.; Siddiki, B. B.; Chung, Y.-S.; Okuno, M.; Sowa, M.; Kim, Y. S.; Matta, K. L.; Brockhausen, I. Glycobiology 1994, 4, 873.
8. (d) Hakomori, S.; Zhang, Y. Chem. Biol. 1997, 4, 97.
9. (a) Yogeeswaran, G.; Stein, B. S.; Sebastian, H. Cancer Res. 1978, 38, 1336.
10. (b) Roth, J.; Zuber, C.; Wagner, P.; Taatjes, D. J.; Weisgerber, C.; Heitz, P. U.; Goridis, C.; Bilter-Suermann, D. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 2999.
11. (c) Sell, S. Human Pathol. 1990, 21, 1003.
12. (d) Scheidegger, E. P.; Lackie, P. M.; Papay, J.; Roth, J. Lab. Invest. 1994, 70, 95.
13. (e) Takano, R.; Muchmore, E.; Dennis, J. W. Glycobiology 1994, 4, 665.
14. Jourdian, G. W.; Dean, L.; Roseman, S. J. Biol. Chem. 1971, 246, 430.
15. (a) Mahal, L. K.; Yarema, K. J.; Bertozzi, C. R. Science 1997, 276, 1125.
16. (b) Yarema, K. J.; Mahal, L. K.; Bruehl, R. E.; Rodriguez, E. C.; Bertozzi, C. R. J. Biol. Chem. 1998, 273, 31168.
17. Peracetylated N-levulinoylmannosamine is metabolized 200-fold more efficiently than the free sugar used in previous studies (ref 7) due to increased cellular uptake, which is followed by deacetylation by cytosolic esterases.
18. (a) Brownlee, M.; Vlassara, H.; Kooney, A.; Ulrich, P.; Cerami, A. Science 1986, 232, 1629.
19. (b) Vasan, S.; Zhang, X.; Zhang, X.; Kapurniotu, A.; Bernhagen, J.; Teichberg, S.; Basgen, J.; Wagle, D.; Shih, D.; Terlecky, I.; Bucala, R.; Cerami, A.; Egan, J.; Ulrich, P. Nature 1996, 382, 275.
20. Williams, M. A.; Rapoport, H. J. Org. Chem. 1993, 58, 1151.
21. 3+ are similar to those of GdDTPA, as is its tissue distribution in laboratory animals. Deal, K. A.; Ramunas, R. J.; Martell, A. E.; Welsh, M. J. J. Med. Chem. 1996, 39, 3096.
22. Diamandis, E. P.; Christopoulos, T. K. Anal. Chem. 1990, 62, A1149+.
23. These concentrations are similar to those achieved in serum following clinical administration of Magnevist (1.5-5 g/patient) (ref 2).
24. Blomberg, K.; Granberg, C.; Hemmila, I.; Lövgren, T. J. Immunol. Methods 1986, 86, 225.
25. Elster, A. D.; Jackels, S. C.; Allen, N. S.; Marrache, R. C. Am. J. Neural Radiol. 1989, 10, 1137.
26. Mutant cell lines were derived by multiple rounds of magnetic particle selection using a protocol that is briefly described in the Supporting Information and will be presented in detail elsewhere.
27. Kawaguchi, T.; Matsumoto, I.; Osawa, T. J. Biol. Chem. 1974, 249, 2786.
28. Moats, R. A.; Fraser, S. E.; Meade, T. J. Angew. Chem., Int. Ed. Engl. 1997, 36, 726.
29. 8 cells/ mL in a typical tissue. Shreve, P.; Aisen, A. M. Magn. Reson. Med. 1986, 3, 336.